His primary scientific interests are in Internal medicine, Immunology, Incidence, Acquired immunodeficiency syndrome and Epidemiology. His Internal medicine research includes elements of Lipodystrophy, Endocrinology and Surgery. His Lipodystrophy study integrates concerns from other disciplines, such as Stavudine and Lipoatrophy.
His Incidence study incorporates themes from Survival rate, Cancer, Hepatitis C and Relative risk. Matthew Law interconnects Developed country, Cohort study, Non-Hodgkin's lymphoma, Viral load and Risk factor in the investigation of issues within Acquired immunodeficiency syndrome. Matthew Law has included themes like Psychiatry, Logistic regression and Heroin in his Epidemiology study.
The scientist’s investigation covers issues in Internal medicine, Immunology, Acquired immunodeficiency syndrome, Cohort and Incidence. His Internal medicine research is multidisciplinary, incorporating perspectives in Surgery, Viral load and Oncology. His research in the fields of Viral disease, Immunopathology and Virus overlaps with other disciplines such as Cart.
His Acquired immunodeficiency syndrome study frequently draws connections to adjacent fields such as Pediatrics. His work deals with themes such as Cohort study and Hazard ratio, which intersect with Cohort. His Incidence research integrates issues from Hepatitis C and Epidemiology.
Matthew Law mainly investigates Internal medicine, Oncology, Genome-wide association study, Melanoma and Confidence interval. His Internal medicine course of study focuses on Cutaneous melanoma and Prospective cohort study and Germline. His research on Oncology also deals with topics like
In his work, Relative risk is strongly intertwined with Genetic association, which is a subfield of Genome-wide association study. Matthew Law has researched Confidence interval in several fields, including Body mass index, Kidney disease and Renal function. Matthew Law combines subjects such as Interquartile range, Regimen, Acquired immunodeficiency syndrome, Viral load and Pediatrics with his study of Cohort.
His main research concerns Internal medicine, Genome-wide association study, Hepatitis C, Disease and Oncology. Cancer, Odds ratio, Confidence interval, Meta-analysis and Rate ratio are the primary areas of interest in his Internal medicine study. His Genome-wide association study research incorporates elements of Medical genetics, Allele and Genetic predisposition.
In his research, Liver disease, Hepatitis and Disease burden is intimately related to Hepatitis C virus, which falls under the overarching field of Hepatitis C. His Disease study combines topics in areas such as Stroke, Clinical endpoint, Heart disease and Population study. His research integrates issues of Anal cancer, Carcinoma, Cohort study and MEDLINE in his study of Incidence.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study
Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka.
PLOS ONE (2015)
A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.
Andrew Carr;Katherine Samaras;Samantha Burton;Matthew Law.
AIDS (1998)
Combination antiretroviral therapy and the risk of myocardial infarction
Nina Friis-Møller;Caroline A Sabin;Rainer Weber;Antonella d'Arminio Monforte.
The New England Journal of Medicine (2003)
Class of antiretroviral drugs and the risk of myocardial infarction.
Nina Friis-Moller;Peter Reiss;Caroline A. Sabin;Rainer Weber.
The New England Journal of Medicine (2007)
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study
Rainer Weber;Caroline A Sabin;Nina Friis-Møller;Peter Reiss.
JAMA Internal Medicine (2006)
Cancer Incidence Before and After Kidney Transplantation
Claire M. Vajdic;Stephen P. McDonald;Margaret R. E. McCredie;Marina T. van Leeuwen.
JAMA (2006)
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
Netanya Sandler;Handan Wand;Annelys Roque;Matthew G Law.
The Journal of Infectious Diseases (2011)
Estimating progression to cirrhosis in chronic hepatitis C virus infection.
Anthony J. Freeman;Gregory J. Dore;Matthew G. Law;Max Thorpe.
Hepatology (2001)
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
Colette J Smith;Lene Ryom;Rainer Weber;Philippe Morlat.
The Lancet (2014)
A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome.
Andrew Carr;John Miller;Matthew Law;David A. Cooper.
AIDS (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
University of New South Wales
Pfizer (United States)
Rigshospitalet
University of New South Wales
University of Amsterdam
University College London
Monash University
Macquarie University
University College London
University of Milan
University of Bonn
French Institute for Research in Computer Science and Automation - INRIA
Virginia Tech
University of Louisville
University of Minnesota
University of Oulu
Universiti Putra Malaysia
Stockholm University
Academia Sinica
Texas A&M University
China University of Geosciences
Istituto Giannina Gaslini
Southern Methodist University
Sahlgrenska University Hospital
Leeds Beckett University
McGill University